Question

A 70-year-old with HFrEF (EF 28%) on ACEI, beta-blocker, and MRA remains symptomatic. No diabetes; eGFR 45 mL/min/1.73 m². What drug class should be added to reduce HF hospitalization and CV death?

Accepted Answer

SGLT2 inhibitor

Answer

Ivabradine

Answer

Hydralazine alone

Answer

Digoxin as monotherapy

Answer

Verapamil

Practice question

A 70-year-old with HFrEF (EF 28%) on ACEI, beta-blocker, and MRA remains symptomatic. No diabetes; eGFR 45 mL/min/1.73 m². What drug class should be added to reduce HF hospitalization and CV death?